Visualization of the catheter orifice position for Patient Controlled Analgesia using Carbon dioxide contrast-enhanced ultrasonography, to check the spread of the chemical research

JMACCT ID: JMA-IIA00253

Registered date:20/06/2016

Basic Information

• Recruitment status: Completed

Health condition(s) or Problem(s) studied

Rotator Cuff Tear
Impingement syndrome
Frozen shoulder
Osteoarthritis of the shoulder
Reccurent Dislocated shoulder
fracture of shoulder

• Date of first enrollment: 02/03/2016
• Target sample size: 30
• Countries of recruitment: Japan
• Study type: INTERVENTIONAL
• Intervention(s): Intervention type:DEVICE. Intervention1:Single arm, Dose form:DEVICE, Route of administration:PERINEURAL, intended dose regimen:A ropivacaine 0.25% 4 ml/hour infusion with mandatory 24 hours.

Outcome(s)

• Primary Outcome: VAS,sensory,MMT. Timepoint:postoperative 24 hour.
• Secondary Outcome: .

Key inclusion & exclusion criteria

• Age minimum: No Limit
• Age maximum: No Limit
• Gender: BOTH
• Include criteria: Patients undergoing a shoulder joint surgery, obtained the consent
• Exclude criteria: Patients with oral anti-platelet drugs

Related Information

• Primary Sponsor: SHIMIZU HAYATO
• Source(s) of Monetary Support: Self-procurement